As of 29 Oct 2026 13:36 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2022/112 (23 Dec 2022): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Selegiline (Eldepryl®) 5mg and 10mg tabletsaffected product · inferred from phrasing | Out of stock, as stated | April 2023precision: a month · window end 30 Apr 2023, derived from “April 2023” | notice of 23 Dec 2022 |
| Rasagiline 1mg tabletsnamed by the source as remaining available · inferred from phrasing · its own page → | Stated as available | — not stated for this line | notice of 23 Dec 2022 |
| Selegiline oral suspensionsnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 23 Dec 2022 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Rasagiline 1mg tablets — named by the source as remaining available (inferred from phrasing)
- Selegiline oral suspensions — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Selegiline
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 23 Dec 2022. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 23 Dec 2022 | Medicine Supply Notification: Selegiline (Eldepryl® ) 5mg and 10mg tablets | Supply notification | Tier 2 | MSN/2022/112 |
Also recorded under
Bracketed names seen in this medicine's notice titles: eldepryl. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2023)1 Selegiline (Eldepryl®) 5mg and 10mg tablets · issued 16 Jan 2023 · valid until until April 2023, as stated · matched by name PDF ↗